Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Diabetes

According to an article published by CBS News, a study concluded that approximately 40 percent of Americans would develop type 2 diabetes during their adult lives. The study, published in The Lancet Diabetes & Endocrinology, analyzed medical...
Sanofi has signed on with MannKind Corp. to purchase rights to Afrezza, the world’s first and only inhaled insulin product, an article published by Bloomberg News reports. MannKind Corp. will be paid $150 million up front, and as much as $925...
A two in one diabetes drug, created by Danish drug maker Novo Nordisk, has been recommended for approval by the European Union, a Reuters article reports. Clinical trials of the drug, Xultophy, have proven that simultaneous consumption of liraglutide...